AZN.LSE
AstraZeneca PLC
Price history
Key metrics
AstraZeneca PLC has paid a dividend for 33 consecutive years and currently yields 1.92%, below its five year average. Its payout ratio is 49%. Dividend Health rates it Very safe at 88 out of 99, with high confidence.
Data as of 22 Sept 2026
Next dividend
Per share
$2.17
Frequency
Final
Declared
—
Ex-date
22 Feb 2027
in 153 days
Pay date
26 Mar 2027
estimated
Dividend health
Confidence High · Defensive profile · as of 22 Sept 2026
Total return
£10,000 invested is £32,404 today: £14,632 from the share price and £7,772 from dividends reinvested.
Total return +224.04%. Price alone returned +146.32% over the same window.
Assumes every dividend is reinvested on its ex-dividend date, before tax and dealing costs.
How it compares
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Annual dividends per share
Dividends paid in USD while AZN.LSE is listed in GBP · based on AZN.LSE's fiscal years ending in December
Dividend Policy
The Board has adopted a progressive dividend policy, intending to maintain or grow the dividend each year but, recognising that some earnings fluctuations are to be expected, the annual dividend will reflect the Board's view of the earnings prospects over the entirety of the investment cycle. The Board's aim is to continue to strike a balance between the interests of the business, financial creditors and the Company's shareholders. After providing for investment in the business, supporting the progressive dividend policy and maintaining a strong, investment-grade credit rating, the Board will keep under review potential investment in immediately earnings-accretive, value-enhancing opportunities.
Dividend History
| Ex-Date | Amount | Status |
|---|---|---|
| 09 Aug 272027-08-09 | £0.7917 | Estimated |
| 22 Feb 272027-02-22 | £1.6208 | Estimated |
| 06 Aug 262026-08-06 | £0.7876 | Paid |
| 19 Feb 262026-02-19 | £1.6105 | Paid |
| 07 Aug 252025-08-07 | £0.7678 | Paid |
| 20 Feb 252025-02-20 | £1.6640 | Paid |
| 08 Aug 242024-08-08 | £0.7846 | Paid |
| 22 Feb 242024-02-22 | £1.5558 | Paid |
| 10 Aug 232023-08-10 | £0.7336 | Paid |
| 23 Feb 232023-02-23 | £1.6395 | Paid |
| 11 Aug 222022-08-11 | £0.7612 | Paid |
| 24 Feb 222022-02-24 | £1.4731 | Paid |
| 12 Aug 212021-08-12 | £0.6515 | Paid |
| 25 Feb 212021-02-25 | £1.3579 | Paid |
| 13 Aug 202020-08-13 | £0.6874 | Paid |
| 27 Feb 202020-02-27 | £1.4715 | Paid |
| 08 Aug 192019-08-08 | £0.7408 | Paid |
| 28 Feb 192019-02-28 | £1.4339 | Paid |
| 09 Aug 182018-08-09 | £0.7091 | Paid |
| 15 Feb 182018-02-15 | £1.3585 | Paid |
| 10 Aug 172017-08-10 | £0.6908 | Paid |
| 16 Feb 172017-02-16 | £1.5304 | Paid |
| 11 Aug 162016-08-11 | £0.6935 | Paid |
| 18 Feb 162016-02-18 | £1.3012 | Paid |
| 13 Aug 152015-08-13 | £0.4857 | Paid |
| 19 Feb 152015-02-19 | £1.0253 | Paid |
| 13 Aug 142014-08-13 | £0.4857 | Paid |
| 19 Feb 142014-02-19 | £1.0253 | Paid |
| 14 Aug 132013-08-14 | £0.4857 | Paid |
| 13 Feb 132013-02-13 | £1.0253 | Paid |
| 08 Aug 122012-08-08 | £0.4857 | Paid |
| 15 Feb 122012-02-15 | £1.0523 | Paid |
| 03 Aug 112011-08-03 | £0.4587 | Paid |
| 02 Feb 112011-02-02 | £0.9983 | Paid |
| 04 Aug 102010-08-04 | £0.3777 | Paid |
| 03 Feb 102010-02-03 | £0.9228 | Paid |
| 05 Aug 092009-08-05 | £0.3184 | Paid |
| 04 Feb 092009-02-04 | £0.8094 | Paid |
| 06 Aug 082008-08-06 | £0.2968 | Paid |
| 06 Feb 082008-02-06 | £0.7285 | Paid |
| 08 Aug 072007-08-08 | £0.2806 | Paid |
| 07 Feb 072007-02-07 | £0.6637 | Paid |
This page is for informational purposes only and does not constitute investment advice. Past dividend payments are not a guarantee of future payments. All data is sourced from public market data and may be delayed. Always do your own research before making any investment decisions.
Your dividend income, mapped.
Free for up to 25 holdings. No credit card. Import your first portfolio in under a minute.
Get started free